 |
Maytansinoid DM-1 Conjugated Humanized Monoclonal Antibody N901 |
|---|---|
| Trade Name | |
| Orphan Indication | Small cell lung cancer |
| USA Market Approval | USA |
| USA Designation Date | 2010-08-17 00:00:00 |
| Sponsor | ImmunoGen, Inc.;830 Winter Street;Waltham, Massachusetts, 02451 |
